Two double-blind, controlled studies comparing chlorethate, a new sedative-tranquilizer, with meprobamate and with phenobarbital.
D001008:Anxiety Disorders / Q000188:drug therapy; D002728:Chlorohydrins / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005023:Ethylene Chlorohydrin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008620:Meprobamate / Q000009:adverse effects / Q000627:therapeutic use*; D010634:Phenobarbital / Q000009:adverse effects / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D002728:Chlorohydrins; D006993:Hypnotics and Sedatives; D014149:Tranquilizing Agents; D005023:Ethylene Chlorohydrin; D008620:Meprobamate; D010634:Phenobarbital